Wolverine Trading’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-12,600
Closed -$113K 5808
2016
Q3
$113K Sell
12,600
-12,200
-49% -$86.7K ﹤0.01% 4131
2016
Q2
$133K Buy
+24,800
New +$127K ﹤0.01% 3508

Wolverine Trading's RPTP Position: Q3 2016 in Review

Wolverine Trading sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 13,466 shares — an estimated $95.7K sold.

Wolverine Trading first reported a position in RPTP in Q2 2016 and held it in 1 quarter. The position peaked at $72K in Q2 2016. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Wolverine Trading reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Wolverine Trading sold 13,466 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $95.7K.
  • Wolverine Trading first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2016 and held it in 1 quarter.
  • Wolverine Trading's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $72K in Q2 2016.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Wolverine Trading's 13F filing for Q3 2016, filed 14 Nov 2016.